Mineralys Therapeutics Inc (MLYS)
Mineralys Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Mineralys Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Myomo Reports Third Quarter 2025 Financial and Operating Results
Oculis Reports Q3 2025 Financial Results and Provides Company Update
enGene to Host Conference Call to Provide Update on Pivotal Cohort of LEGEND Trial
enGene to Host Conference Call to Provide Update on Pivotal Cohort of LEGEND Trial
GenesisX Robotic Magnetic Navigation System Receives U.S. FDA Clearance
Neurocrine Biosciences Provides Update on Phase 2 Study of NBI-1070770 in Adults with Major Depressive Disorder
enGene to Host Conference Call to Provide Update on Pivotal Cohort of LEGEND Trial
enGene to Host Conference Call to Provide Update on Pivotal Cohort of LEGEND Trial
Oculis birtir uppgjör fyrir þriðja ársfjórðung 2025 og kynnir áfanga í rekstri félagsins